Daniel Woo1, Jonathan Rosand, Chelsea Kidwell, Jacob L McCauley, Jennifer Osborne, Mark W Brown, Sandra E West, Eric W Rademacher, Salina Waddy, Jamie N Roberts, Sebastian Koch, Nicole R Gonzales, Gene Sung, Steven J Kittner, Lee Birnbaum, Michael Frankel, Fernando Daniel Testai, Christiana E Hall, Mitchell S V Elkind, Matthew Flaherty, Bruce Coull, Ji Y Chong, Tanya Warwick, Marc Malkoff, Michael L James, Latisha K Ali, Bradford B Worrall, Floyd Jones, Tiffany Watson, Anne Leonard, Rebecca Martinez, Ralph I Sacco, Carl D Langefeld. 1. From the University of Cincinnati, College of Medicine, OH (D.W., J.O., M.F.); Massachusetts General Hospital, Harvard Medical School, Boston, MA (J.R.); Department of Neurology, Georgetown University Medical Center, Washington, DC (C.K.); John P. Hussman Institute for Human Genomics, University of Miami, FL (J.L.M., S.E.W.); Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC (M.W.B., C.D.L.); Institute for Policy Research, University of Cincinnati, OH (E.W.R.); National Institute of Neurological Disorders and Stroke, Bethesda, MD (S.W., J.N.R.); University of Miami, Miller School of Medicine, FL (S.K., R.I.S.); University of Texas Medical School-Houston, TX (N.R.G., R.M.); University of Southern California, Neurocritical Care and Stroke Division, Los Angeles, CA (G.S.); University of Maryland, Baltimore Veterans Administration Medical Center, MD (S.K.); University of Texas Health Science Center at San Antonio, TX (L.B., F.J., A.L.); Emory University, Grady Memorial Hospital, Atlanta, GA (M.F.); University of Illinois at Chicago Medical Center, IL (F.D.T.); Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX (C.E.H.); Columbia University, New York, NY (M.S.V.E.); University of Arizona, Tucson, AZ (B.C.); St. Luke's-Roosevelt Hospital Center, New York, NY (J.Y.C.); University of California San Francisco, Fresno, CA (T.W.); University of New Mexico, Albuquerque, NM (M.M.); Department of Anesthesiology, Duke University, Durham, NC (M.L.J.); University of California, Los Angeles, CA (L.K.A.); Department of Neurology and Public Health Sciences, University of Virginia, Charlottesville, VA (B.B.W.); and Department of Neurology, University of Maryland School of Medicine, Baltimore, MD (T.W.).
Abstract
BACKGROUND AND PURPOSE: Epidemiological studies of intracerebral hemorrhage (ICH) have consistently demonstrated variation in incidence, location, age at presentation, and outcomes among non-Hispanic white, black, and Hispanic populations. We report here the design and methods for this large, prospective, multi-center case-control study of ICH. METHODS: The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study is a multi-center, prospective case-control study of ICH. Cases are identified by hot-pursuit and enrolled using standard phenotype and risk factor information and include neuroimaging and blood sample collection. Controls are centrally identified by random digit dialing to match cases by age (±5 years), race, ethnicity, sex, and metropolitan region. RESULTS:As of March 22, 2013, 1655 cases of ICH had been recruited into the study, which is 101.5% of the target for that date, and 851 controls had been recruited, which is 67.2% of the target for that date (1267 controls) for a total of 2506 subjects, which is 86.5% of the target for that date (2897 subjects). Of the 1655 cases enrolled, 1640 cases had the case interview entered into the database, of which 628 (38%) were non-Hispanic black, 458 (28%) were non-Hispanic white, and 554 (34%) were Hispanic. Of the 1197 cases with imaging submitted, 876 (73.2%) had a 24 hour follow-up CT available. In addition to CT imaging, 607 cases have had MRI evaluation. CONCLUSIONS: The ERICH study is a large, case-control study of ICH with particular emphasis on recruitment of minority populations for the identification of genetic and epidemiological risk factors for ICH and outcomes after ICH.
RCT Entities:
BACKGROUND AND PURPOSE: Epidemiological studies of intracerebral hemorrhage (ICH) have consistently demonstrated variation in incidence, location, age at presentation, and outcomes among non-Hispanic white, black, and Hispanic populations. We report here the design and methods for this large, prospective, multi-center case-control study of ICH. METHODS: The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study is a multi-center, prospective case-control study of ICH. Cases are identified by hot-pursuit and enrolled using standard phenotype and risk factor information and include neuroimaging and blood sample collection. Controls are centrally identified by random digit dialing to match cases by age (±5 years), race, ethnicity, sex, and metropolitan region. RESULTS: As of March 22, 2013, 1655 cases of ICH had been recruited into the study, which is 101.5% of the target for that date, and 851 controls had been recruited, which is 67.2% of the target for that date (1267 controls) for a total of 2506 subjects, which is 86.5% of the target for that date (2897 subjects). Of the 1655 cases enrolled, 1640 cases had the case interview entered into the database, of which 628 (38%) were non-Hispanic black, 458 (28%) were non-Hispanic white, and 554 (34%) were Hispanic. Of the 1197 cases with imaging submitted, 876 (73.2%) had a 24 hour follow-up CT available. In addition to CT imaging, 607 cases have had MRI evaluation. CONCLUSIONS: The ERICH study is a large, case-control study of ICH with particular emphasis on recruitment of minority populations for the identification of genetic and epidemiological risk factors for ICH and outcomes after ICH.
Authors: Clive J Hoggart; Eteban J Parra; Mark D Shriver; Carolina Bonilla; Rick A Kittles; David G Clayton; Paul M McKeigue Journal: Am J Hum Genet Date: 2003-06 Impact factor: 11.025
Authors: Chao Tian; David A Hinds; Russell Shigeta; Sharon G Adler; Annette Lee; Madeleine V Pahl; Gabriel Silva; John W Belmont; Robert L Hanson; William C Knowler; Peter K Gregersen; Dennis G Ballinger; Michael F Seldin Journal: Am J Hum Genet Date: 2007-06 Impact factor: 11.025
Authors: Virginia G Wadley; Leslie A McClure; Virginia J Howard; Frederick W Unverzagt; Rodney C Go; Claudia S Moy; Martha R Crowther; Camilo R Gomez; George Howard Journal: Stroke Date: 2007-02-22 Impact factor: 7.914
Authors: Audrey C Leasure; Kevin N Sheth; Mary Comeau; Chad Aldridge; Bradford B Worrall; Anastasia Vashkevich; Jonathan Rosand; Carl Langefeld; Charles J Moomaw; Daniel Woo; Guido J Falcone Journal: Stroke Date: 2019-06-26 Impact factor: 7.914
Authors: Daniel Woo; Guido J Falcone; William J Devan; W Mark Brown; Alessandro Biffi; Timothy D Howard; Christopher D Anderson; H Bart Brouwers; Valerie Valant; Thomas W K Battey; Farid Radmanesh; Miriam R Raffeld; Sylvia Baedorf-Kassis; Ranjan Deka; Jessica G Woo; Lisa J Martin; Mary Haverbusch; Charles J Moomaw; Guangyun Sun; Joseph P Broderick; Matthew L Flaherty; Sharyl R Martini; Dawn O Kleindorfer; Brett Kissela; Mary E Comeau; Jeremiasz M Jagiella; Helena Schmidt; Paul Freudenberger; Alexander Pichler; Christian Enzinger; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Jaume Roquer; Peter Kraft; Alison M Ayres; Kristin Schwab; Jacob L McCauley; Joanna Pera; Andrzej Urbanik; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Eva-Maria Stögerer; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Rainer Malik; Martin Dichgans; Steven M Greenberg; Peter M Rothwell; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Carl D Langefeld; Jonathan Rosand Journal: Am J Hum Genet Date: 2014-03-20 Impact factor: 11.025
Authors: Russell P Sawyer; Padmini Sekar; Jennifer Osborne; Steven J Kittner; Charles J Moomaw; Matthew L Flaherty; Carl D Langefeld; Christopher D Anderson; Jonathan Rosand; Daniel Woo Journal: Neurology Date: 2018-06-29 Impact factor: 9.910
Authors: Ching-Jen Chen; Dale Ding; Natasha Ironside; Thomas J Buell; Andrew M Southerland; Daniel Woo; Bradford B Worrall Journal: World Neurosurg Date: 2019-02-08 Impact factor: 2.104
Authors: Aaron S Lord; Carl D Langefeld; Padmini Sekar; Charles J Moomaw; Neeraj Badjatia; Anastasia Vashkevich; Jonathan Rosand; Jennifer Osborne; Daniel Woo; Mitchell S V Elkind Journal: Stroke Date: 2014-10-14 Impact factor: 7.914
Authors: Kyle B Walsh; Daniel Woo; Padmini Sekar; Jennifer Osborne; Charles J Moomaw; Carl D Langefeld; Opeolu Adeoye Journal: Circulation Date: 2016-10-13 Impact factor: 29.690
Authors: Soo Young Kwon; Ahmed Z Obeidat; Padmini Sekar; Charles J Moomaw; Jennifer Osborne; Fernando D Testai; Sebastian Koch; Merredith R Lowe; Stacie Demel; Elisheva R Coleman; Matthew Flaherty; Daniel Woo Journal: Clin Neurol Neurosurg Date: 2020-02-07 Impact factor: 1.876
Authors: Meredith P Murphy; Joji B Kuramatsu; Audrey Leasure; Guido J Falcone; Hooman Kamel; Lauren H Sansing; Christina Kourkoulis; Kristin Schwab; Jordan J Elm; M Edip Gurol; Huy Tran; Steven M Greenberg; Anand Viswanathan; Christopher D Anderson; Stefan Schwab; Jonathan Rosand; Fu-Dong Shi; Steven J Kittner; Fernando D Testai; Daniel Woo; Carl D Langefeld; Michael L James; Sebastian Koch; Hagen B Huttner; Alessandro Biffi; Kevin N Sheth Journal: Stroke Date: 2018-11 Impact factor: 7.914